COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

GALLEX 4 - Long-Term Extension Study to Evaluate Tesaglitazar Therapy in Patients With Type 2 Diabetes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00300105
Recruitment Status : Terminated (The development program has been terminated)
First Posted : March 8, 2006
Last Update Posted : March 17, 2008
Information provided by:

No Study Results Posted on for this Study
Recruitment Status : Terminated
Primary Completion Date : No date given
Actual Study Completion Date : December 2006